Maricann Group (CSE: MARI) OTCQB: MRRCF), the Canadian medical cannabis producer based on Toronto, announced that Scott Langille will become its new CFO.

Mr Langille has over 30 years of experience in the pharmaceutical industry in Canada and the United States.  He was formerly CFO of Tribute Pharmaceuticals, which was sold to Pozen for US $160 million. He also served as CFO of Virexx Medical Corp, a biotech firm, and was Vice President at Biovail Pharmaceuticals.

Maricann is a vertically integrated producer of medical cannabis with a facility in Langton Ontario. They have 8,000 registered patients and fully funded 217,000 sq ft of cultivation and support space.

Source: Maricann Group

Leave a Reply